Skip to content
Study details
Enrolling now

Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder

Milky Kohno
NCT IDNCT06426303ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

100

Study length

about 4.7 years

Ages

18–60

Locations

1 site in OR

What this study is about

This trial is testing whether trauma affects emotion regulation, inflammation, and brain function differently between men and women with alcohol use disorder. It aims to determine how naltrexone impacts these factors and its effectiveness in reducing alcohol cravings and promoting abstinence in both sexes.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Naltrexone

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Injection / IVintramuscular

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

naltrexone

Drug routes

injection, intramuscular

Endpoints

Primary: Change from baseline in alcohol use (number of drinking days, amount used per day)

Secondary: Change from baseline in craving (include craving measures/questionnaires), Change from baseline in neuropsychological testing scores

Body systems

Psychiatry / Mental Health